Dearsir, N on-systemic,oculartoxicitycausedbymedications usedinhighlyactiveantiretroviraltherapy(HAART) forhumanimmunodeficiencyvirus(HIV)infectionisan uncommonadverseevent [1] .Roe [2] initiated3wkafterdiscontinuationofritonovir.Posterior placoidchorioretinitishasbeenreportedwithsyphilis [3] ; however,wedonotbelievethemacularfindingsinour patientweresyphilisrelated,inlightofimprovementin clinicalexamination,visualacuityto20/25andSD-OCT beforethesyphilistreatmentwasstarted;Ritonavirismore likelytobetheculprit.Also,theFAofourpatientlackedthe typicallatestainingthatisnotedwithplacoidchorioretinitis [4] . Roe [2] recentlyreportedthreecasesofretinalpigment epitheliopathyinHIV-positivepatientsreceivingRitonavir. Ritonaviris99%proteinboundandmetabolizedintheliver throughcytochromeP-450pathways.Ritonavirtoxicityis dose-related.Itwasshowedthatevenamoderateliver impairmentwoulddoubleitsserumlevel [2] .Itisprudentto believemildliverdysfunction2mopriortoocularsymptoms inourpatientwouldbethetriggeringeventwhichcaused RitonavirserumlevelsincreasedtoRitonavirtoxiclevel; eventhoughithadbeenwelltoleratedfortheprevioussix years.IncontrasttothreepatientsinRoe 'sreport [2] , RPEchangesinourpatientswereunilateral,mildand transient.ItmaybeareflectionofanearlydiagnosisofRPE toxicityinourcasesuchthatthechangeswerereversible witharapidimprovementinvisualacuityandclinical findingswithdiscontinuationofthedrug.
